B1a lymphocytes in ulcerative colitis

International Journal of Colorectal Disease

Volumn 22, Issue 9, 2007, Pages 1005-1011

  Polese, Lino ^a,b   De Franchis, Giuseppe ^a   Scarpa, Marco ^a   Sturniolo, Giacomo C ^a   Ruffolo, Cesare ^a   Norberto, Lorenzo ^a   Frego, Mauro ^a   D'Amico, Davide F ^a   Angriman, Imerio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

B1a cells; CD5; Restorative proctocolectomy; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; CD5 ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL POLYPOSIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROCTOCOLECTOMY; ULCERATIVE COLITIS;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; ANTIGENS, CD5; COLITIS, ULCERATIVE; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE;

EID: 34848926490     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0298-7     Document Type: Article

References (35)

1. Radford-Smith G (1997) Ulcerative colitis: An immunological disease? Baillières Clin Gastroenterol 11:35-52
2. Kraehenbuhl JP, Corbett M (2004) Keeping the gut microflora at bay. Science 303:1624-1625
3. Baumgarth N, Tung JW, Herzenberg LA (2005) Inherent specificities in natural antibodies: A key to immune defense against pathogen invasion. Springer Semin Immunopathol 26:347-362
4. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38:365-375
5. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM (2000) A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:2222-2226
6. Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P (2004) Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3:516-523
7. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M (1992) An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87:971-976
8. Baron JH, Connel AM, Lennard-Jones JE (1964) Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1:89-92
9. Floren CH, Benoni C, Willen R (1987) Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 22:458-462
10. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF (1994) Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index. Mayo Clinic Proc 69:409-415
11. Dougados M, Van der Linden S, Juhin R (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218-1227
12. Senju M, Hulstaert F, Lowder J, Jewell DP (1991) Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut 32:779-783
13. Herzenberg LA (2000) B1 cells: The lineage question revisited. Immunol Rev 175:9-22
14. Hayakawa K, Hardy RR (2000) Development and function of B1 cells. Curr Opin Immunol 12:346-353
15. Su IH, Tarakhovsky A (2000) B-cells: Orthodox or conformist? Curr Opin Immunol 12:191-194
16. Youinou P, Jamin C, Lydyard PM (1999) CD5 expression in human B-cell populations. Immunol Today 20:312-316
17. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S (1996) CD-5 mediated negative regulation of antigen receptor-induced growth signals in B-1 cells. Science 274:1906-1909
18. Sen G, Bikah G, Venkataraman C, Bondada S (1999) Negative regulation of antigen receptor-mediated signalling by constitutive association of CD5 with SHP-1 protein tyrosine phosphatase in B-1 cells. Eur J Immunol 29:3319-3328
19. Masmoudi H, Mota-Santos T, Huetz F, Coutinho a, Cazenave PA (1990) All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol 2:515-520
20. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD, Herzenberg LA (1984) Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM antibodies. Proc Natl Acad Sci U S A 81:2494-2498
21. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL (1987) Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 236:77-81
22. Brennan F, Plater-Zyberk C, Maini RN, Feldmann M (1989) Coordinate expansion of "fetal type" lymphocytes (TCR γδ+ T and CD5+ B) in rheumatoid arthritis and primary Sjogren's syndrome. Clin Exp Immunol 77:175-178
23. Ebo D, DeClerck LS, Bridts CH, Stevens WJ (1994) Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjogren's syndrome. Relationship with disease activity and treatment. In Vivo 8:577-580
24. Seidi OA, Semra YK, Sharief MK (2002) Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis. J Neuroimmunol 133:205-210
25. Youinou P, Renaudineau Y (2004) The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases. Thromb Res 114:363-369
26. Neil GA, Summers RW, Cheyne BA, Capenter C, Huang WL, Kansas GS, Waldshcmidt TJ (1992) CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease. Dig Dis Sci 37:1390-1395
27. Rizzello F, Gionchetti P, Venturi A, Amadini C, Romagnoli R, Campieri M (2002) Review article: Monitoring activity in ulcerative colitis. Aliment Pharmacol Ther 16(Suppl 4):3-6
28. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegard NH (2000) Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 95:359-367
29. Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J (1986) Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 8:647-650
30. Dearing WH, McGuckin WH, Elveback LR (1969) Serum alpha1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology 56:295-303
31. Fagan EA, Dyck RF, Maton PN, Hodgson HJ, Chadvick VS, Petrie A, Pepys MB (1982) Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 12:351-360
32. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426-431
33. Solem CA, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11:707-712
34. Fiocchi C (1998) Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115:182-205
35. Ruthlein J, Ibe M, Burghardt W, Mossner J, Auer IO (1992) Immunoglobulin G (IgG), IgG1 and IgG2 determination from endoscopy biopsy specimen in control, Crohn's disease and ulcerative colitis subjects. Gut 33:507-512